Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Eufets GmbH

EUFETS GmbH, a subsidiary of BioNTech AG specializes in providing services in the area of development and manufacture of cell-based and gene-based therapeutics. EUFETS possesses comprehensive know-how in the development and production of stem cell preparations, retroviral vectors, and genetic modification of primary cells and cell lines. Since 1999, the company has been GMP-certified, and is meanwhile recognized as a leading producer of retroviral vectors for clinical trials worldwide. Since 2012, EUFETS has also added the GMP manufacturing of in vitro transcribed mRNA to its portfolio. *

 

Period Start 1997-01-01 established
Period End 2017-10-04 renamed
  Group BioNTech (Group)
  Today BioNTech Innovative Manufacturing Services GmbH
  Successor BioNTech Innovative Manufacturing Services GmbH
Products Industry cell therapy
  Industry 2 contract manufacturing (biologicals)
Person Person Kühlcke, Klaus (BioNTech 201309 Managing Director of Eufets GmbH)
     
  Street 66 Vollmersbachstr.
  City 55743 Idar-Oberstein
  Tel +49-6781-9855-0
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2023-12-30

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for BioNTech (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top